deep expertise.
P95 provides flexible epidemiology research solutions for vaccines and infectious diseases tailored to the specific research needs of each unique project.
Our experienced global team of 300 staff supports the design and execution of observational studies and real-world data analysis for vaccines and infectious diseases, generating critical insights into disease burden, vaccine effectiveness, treatment outcomes, and healthcare resource utilization.
Comprehensive Epidemiological Expertise
Data-Driven Insights for Informed Decisions
Tailored RWE Solutions for Diverse Regions
p95: Comprehensive Epidemiology and RWE Solutions for Vaccines and Infectious Diseases
Vaccine research is not restricted to the laboratory: To make a difference to people in the real world, vaccine development needs to be connected to the world via epidemiology and pharmacovigilance. Gaining access to epidemiological and real-world data and integrating this into global health studies are essential steps to informing vaccine clinical trials and evaluating the effectiveness and safety of vaccines and treatments in the real world following authorization.
At P95, our global teams of epidemiologists, study operations specialists, safety staff, data scientists, and medical writers are ready to support all types of epidemiological and real-world evidence (RWE) studies.
Our non-interventional studies (NIS) solutions range from primary data collection, database studies including secondary analysis of extensive electronic health record (EHR) databases, systematic literature reviews (SLRs) to pragmatic randomized control trials (RCTs).
what
where
how
why us
The impact of real-world evidence on drug development
RWE – invaluable clinical evidence from health records, wearables, claims and more – can be used throughout the drug development process to enrich clinical trial data, optimize clinical trial design, and shorten timelines.
At P95, we understand the nuances and intricacies of conducting epidemiological research with real-world data, giving you the benefit of local knowledge combined with scientific expertise.
Whether you need support for a single study or long-term real-world data, P95 delivers data-driven insights, ensuring precise, high-quality outcomes that inform healthcare decision-making. Our access to a wide range of global databases, combined with our robust analytical capabilities, makes P95 the trusted partner for epidemiology and real-world evidence solutions.
Real-world evidence in endemic countries
The burden of many infectious diseases is higher in low- and middle-income countries (LMICs), making RWE studies even more beneficial in regions such as Africa, Latin America, and Southeast Asia.
Using real-world data to track infectious disease outbreaks can feed into vaccine effectiveness studies for infectious diseases. By partnering with P95 for vaccine research, you can access our regional specialization and expertise in conducting epidemiological research in endemic countries.
Our Therapeutic Programs
Our clients deserve to work with the foremost experts in each field. That is why we have structured our team into four specialized therapeutic programs—Viral, Bacterial, Global, and Non-Communicable Diseases (NCD).
Each program is staffed with experts who bring unparalleled knowledge and experience in their respective areas across a wide range of pathogens. Backed by over 35 epidemiologists, our multidisciplinary approach ensures that we deliver the highest level of expertise and tailored solutions for every project.
differentiators
- Unmatched expertise and experience: we have completed over 300 epidemiological projects, including primary data collection studies non-interventional studies (NIS), systematic literature reviews (SLRs), and database studies
- Therapeutic Program: we provide unrivaled expertise, backed by 35 in-house epidemiologists working across our four therapeutic programs: Viral, Bacterial, Global, and Non-Communicable Diseases (NCD)
- Extensive partner network: we excel in coordinating networks of partner organizations, and we leverage those partners’ resources effectively, streamlining the conduct of non-intrevational studies
- Flexible solutions and a personalized approach, customized around the individual needs of each of our clients: we are used to adapting resources to project needs and can tap into a pool of experienced and qualified team members
- Project leadership and accountability: our flat management structure gives you access to our executive management team for oversight and issue escalation
Real-world evidence study design
As experts in designing real-world evidence studies, we provide non-interventional studies focusing on disease burden, safety, healthcare resource utilization, and treatment effectiveness.
Our Real-World Evidence (RWE) study design expertise covers prospective and retrospective data collection, post-authorization safety surveillance, pregnancy registries, vaccine effectiveness, test-negative case-control (TNCC), seroprevalence, safety cohorts, and more. Our team can support every step of your research, from feasibility and protocol development to site monitoring, data capture, and comprehensive reporting.
services
Non-interventional studies on:
burden of disease, safety, effectiveness, healthcare resource utilization, and others
Systematic literature reviews (SLRs)
Primary data collection
- Feasibility
- Protocol development
- Investigator identification
- Data capture, transfer and storage
- Data and site monitoring
- Analysis and reporting
Secondary data collection
- Feasibility and fit-for-purpose assessment
- Protocol development
- Analysis and reporting